Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
HBMN | Switzerland | CHF | Delayed | |
HBMNE | Switzerland | CHF | Delayed | |
0QOC | London | CHF | Real-time |
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds. It also seeks to finance spin-offs of product lines or departments from larger corporations and the expansion or restructuring of established companies, seed stages, venture capital, expansion capital stages, spin-offs, and buyouts. The fund prefers to invest in the private and public companies in the healthcare sector with a focus on human medicine, drugs, pharma , biopharma, biotechnology, diagnostics, medical technology, and related industries. It seeks to make initial investments in companies whose primary products are in clinical development or the immediately preceding stage. The fund typically invests globally with a focus on Asia Pacific, Asia, North America, and Europe. In case of public companies, it focuses on those which originate from its private portfolio. The fund increases its investment in portfolio companies by participating in a follow-on financing or after the portfolio company’s IPO. It may acquire majority participations in portfolio companies, usually takes a seat on the portfolio company’s Board of Directors, and largely makes equity investments but may also invest through other instruments including convertible bonds, debt securities, structured products, and derivatives. The fund exits its portfolio companies through trade sale or IPO.
Name | Age | Since | Title |
---|---|---|---|
Hans Wigzell | 86 | - | Member of Advisory Board |
Hanns Möhler | - | - | Member of Advisory Board |
Rudolf Lanz | 74 | 2003 | Member of Board of Directors |
Urs A. Meyer | - | - | Member of Advisory Board |
Hans Peter Hasler | 68 | 2009 | Chairman of the Board of Directors |
Benedikt Suter | 60 | - | Secretary to the Board of Directors |
Mario Germano Giuliani | 52 | 2012 | Member of Board of Directors |
Xiaoxing Xu | 53 | - | Member of Board of Directors |
Elaine V. Jones | 69 | 2021 | Member of Board of Directors |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review